APA (7th ed.) Citation

RQ, F., CB, M., AC, D., F, A., B, D., MJ, O., . . . SD, O. (2026). Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study. European journal of breast health, 22(3), 318. https://doi.org/10.4274/ejbh.galenos.2026.2026-2-3

Chicago Style (17th ed.) Citation

RQ, Ferreira, et al. "Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study." European Journal of Breast Health 22, no. 3 (2026): 318. https://doi.org/10.4274/ejbh.galenos.2026.2026-2-3.

MLA (9th ed.) Citation

RQ, Ferreira, et al. "Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study." European Journal of Breast Health, vol. 22, no. 3, 2026, p. 318, https://doi.org/10.4274/ejbh.galenos.2026.2026-2-3.